12th Feb 2009 11:40
RNS Number : 2267N
AGI Therapeutics plc
12 February 2009
AGI Therapeutics plc ('AGI' or the 'Company')
Holding in Company
AGI was notified on 12 February 2009 that Polar Capital Healthcare Opportunities Fund had increased its shareholding to 2,590,000 Ordinary Shares representing 3.84% of AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai